Proactive news headlines: OKYO Pharma, MGC Pharmaceuticals, Seeing Machines, AFC Energy...

OKYO Pharma Limited (LON:OKYO; OTCQB:EMMLF) said a non-opioid analgesic it is developing has shown early potential to treat acute and chronic ocular pain. DeepVerge PLC (LON:DVRG) said it has signed a non-binding memorandum of understanding (MOU) with China Resources Environmental Protection Development Limited, a subsidiary of China Resources Group, to enter into a joint venture (JV) for the manufacturing and sale of environmental monitoring equipment. Keywords Studios PLC (LON:KWS) founder Giorgio Guastalla has sold 3mln shares at 2,800p each. Following the sale, non-executive director Guastalla will own just over 500,000 shares, a 0.7% stake. Redx Pharma PLC (LON:REDX) said it had dosed the first three patients in its phase I clinical trial assessing RXC004 used alongside the Bristol Myers Squibb’s anti-PD-1 cancer drug OPDIVO. Frontier IP Group PLC (LON:FIPP) said its portfolio firm, Exscientia, has received an investment of up to US$525mln after closing a Series D funding round led by Japanese conglomerate SoftBank. In a separate announcement, Frontier IP issued an update on its current trading, saying it expects the outcome for the year to June 30, 2021 will be “materially ahead of management expectations”. MGC Pharmaceuticals Ltd’s (ASX:MXC) (LON:MXC) (OTCMKTS:MGCLF) Canadian-based development and North American distribution partner Glow LifeTech (CNSX:GLOW) (FRA:9DO) has submitted an application to Health Canada to obtain product licences for ArtemiC as a Natural Health Product. IXICO PLC (LON:IXI) has won a contract with its largest pharma client, providing its neuroimaging services for a new clinical trial for acute ischemic stroke. Silence Therapeutics PLC (LON:SLN, NASDAQ:SLN) said had received a further US$2mln from commercial partner Mallinckrodt under a deal potentially worth up to US$2bn in milestones and royalties. Seeing Machines Ltd (LON:SEE) has welcomed what it said is “building momentum” in the US for mandatory driving monitoring system (DMS) technology to assist in improving road safety. Tissue Regenix Group PLC (LON:TRX) said it is confident in its prospects once the COVID-19 pandemic has subsided and healthcare procedures return to a normalised level. AFC Energy PLC (LON:AFC) appointed Dr David B. Harvey, a world recognised expert in the field of fuel cell technology and electrochemical systems, as its new chief technology officer, effective from May 2021.  Sativa Wellness Group Inc (LON:SWEL) has appointed Marc Howells as its new chief executive and Anne Tew as its new chief financial officer. NQ Minerals PLC (AQSE:NQMI) said surface trenching (costeaning) at the Beaconsfield Gold Mine in Tasmania, Australia hit strong indications of gold in two areas. Power Metal Resources PLC (LON:POW) is to acquire a 75% strategic interest in a UK special acquisition vehicle which will in turn acquire outright First Development Resources Ltd, an Australian private company. Corero Network Security plc (LON:CNS) has posted its annual report and accounts for 2020 ahead of its annual general meeting on 10 June, with shareholders encouraged to vote by proxy as it will be a closed meeting due to coronavirus restrictions. Greatland Gold PLC (LON:GGP) announced the release of a new corporate presentation ahead of upcoming investor meetings, which it has made available for download from the company website. NR Private Market and Minexia have presented a new collaboration, Gembridge, offering the world’s first regulated community to trade coloured gemstones. Bezant Resources PLC  (LON:BZT) said it has served notice of termination of its transaction agreement dated 4 October 2019 with Singapore-based Mining and Minerals Industries (MMIH). MMIH agreed to buy its 80% stake in the Mankayan copper-gold project in the Philippines but had not met its Total Funding Commitment under the Transaction Agreement, said Bezant, which is taking steps to recover shares transferred to MMJV, a subsidiary of the Singapore concern.  Bezant said is now considering its options over the Mankayan project including whether to retain it as part of its portfolio.